Visalytics
Visalytics
approved EB-2 (NIW)

Field Application Scientist

Biochemistry · Sri Lanka · 2025-04-22

Processing Time
4 days
Decision Date
2025-04-22
Location
New Jersey
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research in biochemistry, specifically focusing on developing innovative protocols and tools for the purification and analysis of plasmid DNA and proteins. This work aims to eliminate technical obstacles in the biopharmaceutical sector to accelerate the development of vaccines and antibodies. The endeavor is designed to enhance biomarker development and ensure the quality and stability of plasma and serum samples used in cancer research.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical bottlenecks in vaccine and antibody development, contributing to U.S. medical advancements and biosecurity.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D. and publication record of 9 journal articles and 22 abstracts demonstrate his leadership and expertise in biochemistry.

3 Balance of Factors Met

The inherent value of the petitioner's work in DNA manufacturing and cancer research makes it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in biochemistry and a strong record of 9 peer-reviewed journal articles and 22 abstracts which garnered 92 citations. The case demonstrated national importance through alignment with biosecurity and marine innovation, supported by two expert recommendation letters. The petition successfully satisfied all three prongs of the Dhanasar framework.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Conference Presentations
Original Contributions
Government Alignment

Similar Cases

Scientist

Biotechnology · Sri Lanka

WeGreened EB-2 (NIW) approved
Ohio 3 days 2024-02-08
The petitioner proposes to continue research on developing new methodologies for engineering and characterizing novel proteins and antibodies. This work aims to further biomedical studies, the biotechnology industry, and healthcare by providing foundations for innovations in therapeutic treatments.
View Case

Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) rfe approved
Illinois 367 days 2025-11-28
The petitioner proposes to use in-depth analysis of biological and chemical samples to advance the understanding of cellular reactions and mechanisms. Her work aims to devise biochemical and biomedical strategies to combat diseases and resolve urgent biomedical challenges, directly improving therapeutic development and public health outcomes.
View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Maryland 5 days 2024-03-20
The petitioner proposes to continue her research on developing biomanufacturing processes to produce therapeutic moieties such as biologics, small molecules, and cell and gene therapies. Her work focuses on achieving optimal-quality treatments for diseases including cancer, inflammation, and rare diseases while expanding the availability of top-tier therapies through biomanufacturing innovations.
View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Maryland 292 days 2025-02-27
The petitioner proposes to develop engineering approaches for the production of therapeutic antibodies and novel antibody-like proteins. Her work focuses on improving clinical outcomes in oncology, immunology, and anti-infection applications by creating tools to overcome therapeutic resistance and metastasis. Additionally, she aims to enhance production efficiency to ensure broader accessibility of life-saving treatments.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Sri Lanka

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-22.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 4 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Sri Lanka All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist